Macron Refused To Take Russian Covid Test
The title of this post is the same as that of this article on the BBC.
These are the first four paragraphs.
French President Emmanuel Macron refused a Russian Covid test ahead of his meeting with Russia’s Vladimir Putin, the Kremlin has confirmed.
The test required a health protocol that was unacceptable and did not fit with the French leader’s schedule, a French source told the BBC.
It follows reports that Mr Macron refused the PCR test over fears the Russians would get hold of his DNA.
The leaders subsequently held a socially-distanced meeting on Monday.
The article is accompanied by an hilarious picture of the two leaders at each end of a long marble table, which is crying out for a caption like Who Isn’t Using Lifebuoy?
Seriously though, if the Russians wanted Macron’s DNA, there are ways.
- Send his water glass or coffee cup to a lab.
- Make sure Macron uses a special toilet that collects his pee, poo and toilet paper.
- It might even be possible to collect it off the marble table.
I suspect that the Russians have collected Macron’s fingerprints from the table for some nefarious purposes.
GSK To Manufacture 60m Doses Of Novavax Covid Vaccine In UK
The title of this post is the same as that as this article in the Financial Times.
As the Novavax Covid-19 vaccine is a two-dose vaccine, that is enough for thirty million people.
Wikipedia gives brief details of the the manufacturing of the vaccine for Canada and the UK in this section entitled Deployment.
On 2 February 2021, the Canadian Prime Minister Justin Trudeau announced that Canada has signed a tentative agreement for Novavax to produce millions of doses of its COVID-19 vaccine in Montreal, Canada, once it is approved for use by Health Canada, making it the first COVID-19 vaccine to be produced domestically.
On 29th March 2021, the UK government announced an order for 60 million doses of the Novax vaccine, which will be manufactured in the UK. FUJIFILM Diosynth Biotechnologies and GlaxoSmithKline will manufacture and fill the orders respectively.
This Google Map shows Barnard Castle in relation to Teesside.
Note.
- The red arrow in the South-West corner of the map indicates the GSK factory at Barnard Castle.
- Teesside is the estuary at the Eastern edge of the map.
- FUJIFILM Diosynth Biotechnologies are located in Billingham, which is on the North bank of the Tees.
The two sites are under an hour apart.
This page on the UK Government web site gives details of the vaccines ordered.
- Adenovirus – Oxford/AstraZeneca – 100 million – Approved and in deployment
Adenovirus – Janssen – 30 million – Phase 3 trials
mRNA – Pfizer/BioNTech – 40 million – Approved and in deployment
mRNA – Moderna – 17 million – Approved
Protein Adjuvant – GlaxoSmithKline/Sanofi Pasteur – 60 million – Phase 1/2 trials
Protein Adjuvant – Novavax 60 million – Phase 3 trials
Inactivated whole virus – Valneva – 60 million – Phase 1/2 trials
Note.
- Type, manufacturer, number and status are shown for each vaccine.
- This is a total of 567 million doses.
It looks to me, that backing four different technologies and seven different partnerships or companies was a successful strategy, as if the Novavax vaccine get approval, as serious commentators like Fergus Walsh of the BBC, think it will, picking four winners in a seven horse race.
GlaxoSmithKline appear to be a big loser in that they backed the French Sanofi Pasteur vaccine, which is still in Phase 1/2 trials. Wikipedia has a section entitled Deployment.
In July 2020, the UK government signed up for 60 million doses of a COVID-19 vaccine developed by GSK and Sanofi. It uses a recombinant protein-based technology from Sanofi and GSK’s pandemic technology. The companies claimed to be able to produce one billion doses, subject to successful trials and regulatory approval, during the first half of 2021. The company also agreed to a $2.1 billion deal with the United States to produce 100 million doses of the vaccine.
Someone appears to have lost billions.
I wonder though, if GSK had developed a plan to fill and finish the sixty million doses for the UK.
So have the fixers in the Joint Committee on Vaccination and Immunisation (JCVI) matched FUJIFILM Diosynth Biotechnologies vaccine manufacturing to GSK’s fill and finish plan to give Novavax a 60 million dose capacity in the UK?
- Both vaccines are of the same type, so can one fill and finish line handle both?
- The Novavax vaccine was trialled in the UK.
- Supplying Europe from Teesside would not be difficult.
Wikipedia seems to indicate, that Novavax like to spread production around. Spain, India and Poland are mentioned.
Conclusion
Every one of sixty million jabs helps.
President Macron was unavailable for comment.
Macron Rex: Interfuctus Est.
The title of this post, is a tagline in the big cartoon in today’s copy of The Times.
It is drawn in the style of the Bayeux Tapestry and has all the players in our spat with the EU.
Many have been shot by syringes.
Does President Macro have a sense of humour?
Try to see a copy and examine the detail!